Asia Team

Home/Team/Asia Team
Asia Team 2018-10-25T15:25:55+00:00

We have extensive experience in all aspects of life sciences finance, including institutional sales, capital markets, investment banking, investor and public relations, sell-side analysis, and buy-side analysis. We have an equally strong foundation in the life sciences (6 Ph.D.s on staff), which enables us to understand our clients’ R&D, regulatory, and commercial strategy. The combination of financial service and life science expertise allow us to best serve our clients’ needs.

Managing Director

Managing Director, Head of Asia

Greg Meiselbach joins LifeSci with a track record of building successful international outreach and business development programs for western companies in emerging markets. Greg founded The Shelburne Group, an advisory firm serving companies on matters of international investor relations, government relations, market entry, stakeholder engagement, and partner development. Greg was also Director for International Affairs at the Biotechnology Innovation Organization (BIO) for five years. In his role, he managed BIO’s international government affairs portfolio for Asia Pacific and worked with BIO’s members to craft international engagement strategies to promote member companies’ business interests abroad. Prior to this, while based out of Singapore, Greg built and managed the Asia Pacific portfolio of Frontier Strategy Group’s Expert Advisory Network, a broad network of in-market experts, professionals, and former officials who supported Frontier Strategy Group’s clients’ expansion into emerging markets. Greg holds a B.A. in Political Science from Tufts University in Medford, MA and speaks conversational Mandarin.